Riffet Marc, Dupont Benoît, Faisant Maxime, Cerasuolo Damiano, Menahem Benjamin, Alves Arnaud, Dubois Fatémeh, Levallet Guénaëlle, Bazille Céline
Department of Pathology, CHU de Caen, 14000 Caen, France.
Department of Gastroenterology, CHU de Caen, 14000 Caen, France.
Int J Mol Sci. 2023 Feb 10;24(4):3573. doi: 10.3390/ijms24043573.
Colorectal cancer is a major public health issue due to its high incidence and mortality. It is, therefore, essential to identify histological markers for prognostic purposes and to optimize the therapeutic management of patients. The main objective of our study was to analyze the impact of new histoprognostic factors, such as tumor deposits, budding, poorly differentiated clusters, mode of infiltration, the intensity of inflammatory infiltrate and the type of tumor stroma, on the survival of patients with colon cancer. Two hundred and twenty-nine resected colon cancers were fully histologically reviewed, and survival and recurrence data were collected. Survival was analyzed using Kaplan-Meier curves. A univariate and multivariate Cox model was constructed to identify prognostic factors for overall survival and recurrence-free survival. The median overall survival of the patients was 60.2 months and the median recurrence-free survival was 46.9 months. Overall survival and recurrence-free survival were significantly worse in the presence of isolated tumor deposits (log rank = 0.003 and 0.001, respectively) and for an infiltrative type of tumor invasion (log rank = 0.008 and 0.02, respectively). High-grade budding was associated with a poor prognosis, with no significant difference. We did not find a significant prognostic impact of the presence of poorly differentiated clusters, the intensity of the inflammatory infiltrate or the stromal type. In conclusion, the analysis of these recent histoprognostic factors, such as tumor deposits, mode of infiltration, and budding, could be integrated into the results of pathological reports of colon cancers. Thus, the therapeutic management of patients could be adjusted by providing more aggressive treatments in the presence of some of these factors.
由于结直肠癌的高发病率和高死亡率,它成为了一个重大的公共卫生问题。因此,识别用于预后目的的组织学标志物并优化患者的治疗管理至关重要。我们研究的主要目的是分析新的组织预后因素,如肿瘤沉积、芽生、低分化簇、浸润方式、炎性浸润强度和肿瘤基质类型,对结肠癌患者生存的影响。对229例切除的结肠癌进行了全面的组织学复查,并收集了生存和复发数据。使用Kaplan-Meier曲线分析生存情况。构建单变量和多变量Cox模型以识别总生存和无复发生存的预后因素。患者的中位总生存时间为60.2个月,中位无复发生存时间为46.9个月。在存在孤立肿瘤沉积时(对数秩分别为0.003和0.001)以及肿瘤浸润为浸润型时(对数秩分别为0.008和0.02),总生存和无复发生存均显著较差。高级别芽生与预后不良相关,但无显著差异。我们未发现低分化簇的存在、炎性浸润强度或基质类型具有显著的预后影响。总之,对这些新的组织预后因素,如肿瘤沉积、浸润方式和芽生的分析可纳入结肠癌病理报告结果中。因此,在存在某些这些因素时,可通过提供更积极的治疗来调整患者的治疗管理。